Skip to content

Clinical trials

Phase 3 Hemorrhage trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemorrhage Phase: Phase 3 Country / region: Germany Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20072
20081
20091
20101
20131
20141
20151
20181
20192
20201
20211
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Recruiting5
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Idorsia Pharmaceuticals Ltd.2
Pfizer2
Population Health Research Institute2
Alexion Pharmaceuticals, Inc.1
Assistance Publique - Hôpitaux de Paris1
AstraZeneca1
Biotest1
Boehringer Ingelheim1
CSL Behring1
Ethicon, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemorrhage17
Hemophilia A3
Hemophilia B3
Stroke2
Subarachnoid Hemorrhage2
Afibrinogenemia1
Atrial Fibrillation1
Cataplexy1
Hypertension1
Ischemia1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.